As the US’s decision to discontinue the Johnson & Johnson vaccine provokes a new scrutiny for all vaccines based on adenovirus-vector platform, Denmark, one of the most critical countries in Europe when it comes to vaccine safety, has just declared that it will permanently ban AstraZeneca’s coronavirus vaccine following a safety review.

The decision to ban the jab was taken after it was reportedly linked to several serious reactions involving blood clots and bleeding in patients with low blood platelet counts, according to Berlingske.

The vaccine was originally put on hold on March 11 when a 60-year-old Danish woman died shortly after receiving the vaccine. She died with a very unique disease picture, where she was both affected by internal bleeding, a very low platelet count and blood clots. Roughly three dozen similar cases have been reported across the EU.

Cerebral blood clots were characterized as a very rare side effect, the result of random immune system reactions to the adenovirus jabs – or at least that’s what a team of doctors suggested yesterday.

Both the WHO and the EMA have repeatedly maintained that the benefits of using the corona pandemic vaccine outweigh the risks, though the EMA has acknowledged that there’s a possibility of a connection between the vaccines and the rare reactions, which have now been documented in patients who received the AstraZeneca jab, and the J&J jab.

Yesterday, Dr. Peter Marks said US regulators were looking more closely at the adenovirus platform, which was used by AstraZeneca, J&J and Russia’s “Sputnik V” jab.

Denmark and Norway had maintained the pause to examine the vaccine further. But now the authorities in Denmark have decided that there’s enough evidence to permanently suspend the vaccine in their country.

The decision will have a significant impact on the timeline of Denmark’s vaccine rollout, with officials estimating on Wednesday that it could take an extra three months to the vaccinate the entire population.

Meanwhile, in the EU, Commission President Ursula von der Leyen proclaimed that the Continent has reached 100M vaccinations, a milestone made possible by a recent acceleration in the pace of the Continent’s rollout.

In a shocking report that could have dramatic implications for the US vaccine rollout, federal public health authorities in the US have decided to stop administering COVID jabs developed by Johnson & Johnson, and are asking states to do the same. The reason? Authorities have identified six cases of rare and life-threatening blood clots, at least one of which resulted in death.

According to the NYT, which broke the news, all six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition, the officials said.

The FDA published its own advisory shortly after the NYT broke the news.

All federal facilities will halt use of the jab immediately, and the states are expected to follow suit by ordering jabs to be suspended at their vaccination site. Regardless, we imagine most Americans would refuse a JNJ jab now that reports of the blood clots, which also were found to be associated with AstraZeneca vaccines by authorities in Europe.

Federal health agencies on Tuesday will call for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination, officials briefed on the decision said.

All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition, the officials said.

Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.

While the move is framed as a recommendation to health practitioners in the states, the federal government is expected to pause administration of the vaccine at all federally run vaccination sites. Federal officials expect that state health officials will take that as a strong signal to do the same.

The FDA and CDC will jointly examine any potential link between the vaccines and the blood clots. The decision to halt the rollout could “substantially complicate” the country’s vaccination trajectory, and already, markets are looking shakey.

Scientists with the Food and Drug Administration and C.D.C. will jointly examine possible links between the vaccine and the disorder and determine whether the F.D.A. should continue to authorize use of the vaccine for all adults or limit the authorization. An emergency meeting of the C.D.C.’s outside advisory committee has been scheduled for Wednesday, officials said.

An F.D.A. spokeswoman declined to comment.

The move could substantially complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy. Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That concern has driven up some resistance to all vaccines, even though the AstraZeneca version has not been approved for use in the United States.

Supply disruptions at a US factory in Baltimore coincidentally led to a dramatic reduction in supply of Johnson & Johnson vaccines on the market, leading to shortages that prompted a brief slowdown in the US vaccine rollout. Nearly 7 million people have received the JNJ jab so far in the US, and roughly 9 million more doses have been shipped.

White House chief medical adviser – and just about the only talking “expert” the mainstream media will roll out for its audience – Dr. Anthony Fauci, said on Sunday that people who have been vaccinated for COVID-19 should still hold off on gathering indoors to eat or drink.

After introducing him as “America’s doctor,” MSNBC’s Mehdi Hasan asked Fauci, “What is the message to vaccinated and unvaccinated Americans as to what they should and should not be doing right now? For example, eating and drinking indoors in restaurants and bars — is that OK now?”

Fauci responded:

“No, it’s still not OK for the simple reason that the level of infection, the dynamics of infection in the community are still really disturbingly high,” Fauci advised. “Like just yesterday, there were close to 80,000 new infections, and we’ve been hanging around 60,000, 70,000, 75,000.”

“America’s doctor” would go on to add:

“So, if you’re not vaccinated, please get vaccinated as soon as vaccine becomes available to you, and if you are vaccinated, please remember that you still have to be careful and not get involved in crowded situations, particularly indoors where people are not wearing masks,” he stated. “And for the time being, until we show definitively that a person who’s vaccinated does not get this subclinical infection and can spread to others, you should also continue to wear a mask.”

While Fauci seems to only be able to push experimental, in-trial vaccines on the public, with no advice on how to treat or prevent infections outside the jab, we can’t help but highlight again the testimony from professor of medicine at Texas A&M, Dr. Peter McCullough, in front of the Texas senate earlier in the month where he stated that there is “no scientific rationale” for people under 50 with no health risks to ever become vaccinated for COVID-19.

During his testimony, McCullough also focused in on the censorship of COVID treatments from Big Tech social media, saying that if information on treatments could have been widely disseminated and used on patients, fatalities from COVID-19 could have been reduced by 85% .

Watch Dr. McCullough’s testimony below:

********

Get the NEWS YOU NEED sent straight to your inbox by subscribing to our FREE NEWSLETTER below: